FindTrial
Sign In

Effect of intensifying follow-up in the vulnerable phase on prognosis among patients with heart failure

Effect of intensifying follow-up in the vulnerable phase on prognosis among patients with heart failure

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800018555
Enrollment
Unknown
Registered
2018-09-24
Start date
2018-10-01
Completion date
Unknown
Last updated
2018-10-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart Failure

Interventions

Intervention Group:intensifying follow-up in the vulnerable phase
Control Group:non-intensifying follow-up in the vulnerable phase

Sponsors

Fujian Provincial Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. with a confirmed diagnosis of NYHA class II-IV HF or Killip class II-IV; 2. with clear consciousness and normal communication; 3. giving informed consent were eligible for the study; 4. admitted age 18 years of age or older.

Exclusion criteria

Exclusion criteria: 1. with cognitive impairment or unconsciousness; 2. with life-threatening illness that could compromise survival, such as malignant tumors.

Design outcomes

Primary

MeasureTime frame
Rehospitalization rate for one year of heart failure;—

Secondary

MeasureTime frame
heart function classification;self-care ability;living quality;—

Countries

China

Contacts

Public ContactLIN Na

Department of Cardiology, Fujian Provincial Hospital

linnalynn07071@sina.com+86 13615033165

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026